Scientists test Triple-Threat attack on Tough-to-Treat uterine cancer
Disease control
Recruiting now
This early-stage study is testing the safety of combining two cancer drugs (lenvatinib and pembrolizumab) with a short, intense course of pelvic radiation. The goal is to see if this three-part approach is safe and tolerable for people with a specific type of recurrent or inopera…
Phase: PHASE1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC